Literature DB >> 21719283

Benzisothiazolones as modulators of macrophage migration inhibitory factor.

William L Jorgensen1, Alexander Trofimov, Xin Du, Alissa A Hare, Lin Leng, Richard Bucala.   

Abstract

Substituted N-phenylbenzisothiazolones have been investigated as inhibitors of the tautomerase activity of the proinflammatory cytokine n class="Gene">MIF (macrophage migration inhibitory factor). Numerous compounds were found to possess antagonist activity in the low micromolar range with the most potent being the 6-hydroxy analog 1w. Compound 1w and the p-cyano analog 1c were also shown to exhibit significant inhibition of the binding of MIF to its transmembrane receptor CD74. Consistently, both compounds were also found to retard the MIF-dependent phosphorylation of ERK1/2 in human synovial fibroblasts.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719283      PMCID: PMC3139435          DOI: 10.1016/j.bmcl.2011.05.127

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  37 in total

Review 1.  Molecular modeling of organic and biomolecular systems using BOSS and MCPRO.

Authors:  William L Jorgensen; Julian Tirado-Rives
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

Review 2.  Macrophage migration inhibitory factor: a critical component of autoimmune inflammatory diseases.

Authors:  Richard Bucala; Elias Lolis
Journal:  Drug News Perspect       Date:  2005-09

3.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.

Authors:  Robert A Mitchell; Hong Liao; Jason Chesney; Gunter Fingerle-Rowson; John Baugh; John David; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 4.  Autoimmune diseases: MIF as a therapeutic target.

Authors:  Dorothee Greven; Lin Leng; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2010-03       Impact factor: 6.902

5.  Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site.

Authors:  Larry R McLean; Ying Zhang; Hua Li; Yong-Mi Choi; Zuoning Han; Roy J Vaz; Yi Li
Journal:  Bioorg Med Chem Lett       Date:  2010-02-06       Impact factor: 2.823

6.  Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus.

Authors:  Yuriko Sanchez-Zamora; Luis I Terrazas; Alonso Vilches-Flores; Emmanuel Leal; Imelda Juárez; Caroline Whitacre; Aaron Kithcart; James Pruitt; Thais Sielecki; Abhay R Satoskar; Miriam Rodriguez-Sosa
Journal:  FASEB J       Date:  2010-03-04       Impact factor: 5.191

Review 7.  Role of macrophage migration inhibition factor in kidney disease.

Authors:  Hui Y Lan
Journal:  Nephron Exp Nephrol       Date:  2008-07-25

8.  Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.

Authors:  Zoe Cournia; Lin Leng; Sunilkumar Gandavadi; Xin Du; Richard Bucala; William L Jorgensen
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

Review 9.  Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.

Authors:  Heidi Noels; Jürgen Bernhagen; Christian Weber
Journal:  Trends Cardiovasc Med       Date:  2009-04       Impact factor: 6.677

10.  MIF as a glucocorticoid-induced modulator of cytokine production.

Authors:  T Calandra; J Bernhagen; C N Metz; L A Spiegel; M Bacher; T Donnelly; A Cerami; R Bucala
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

View more
  8 in total

1.  Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; William L Jorgensen
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

Review 2.  Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Joshua B Bilsborrow; Edward Doherty; Pathricia V Tilstam; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2019-08-20       Impact factor: 6.902

3.  Homotrimeric macrophage migration inhibitory factor (MIF) drives inflammatory responses in the corneal epithelium by promoting caveolin-rich platform assembly in response to infection.

Authors:  Thomas Reidy; Alexander Rittenberg; Markryan Dwyer; Samantha D'Ortona; Gerald Pier; Mihaela Gadjeva
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

4.  Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B/NS3 proteases.

Authors:  Huiguo Lai; Dengfeng Dou; Sridhar Aravapalli; Tadahisa Teramoto; Gerald H Lushington; Tom M Mwania; Kevin R Alliston; David M Eichhorn; Radhakrishnan Padmanabhan; William C Groutas
Journal:  Bioorg Med Chem       Date:  2012-11-15       Impact factor: 3.641

5.  An Analysis of MIF Structural Features that Control Functional Activation of CD74.

Authors:  Georgios Pantouris; Mansoor Ali Syed; Chengpeng Fan; Deepa Rajasekaran; Thomas Yoonsang Cho; Eric M Rosenberg; Richard Bucala; Vineet Bhandari; Elias J Lolis
Journal:  Chem Biol       Date:  2015-09-10

6.  Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.

Authors:  Joyce Sayegh; Jian Cao; Mike Ran Zou; Alfonso Morales; Lauren P Blair; Michael Norcia; Denton Hoyer; Alan J Tackett; Jane S Merkel; Qin Yan
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

7.  Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.

Authors:  Deepa Rajasekaran; Swen Zierow; Mansoor Syed; Richard Bucala; Vineet Bhandari; Elias J Lolis
Journal:  FASEB J       Date:  2014-07-11       Impact factor: 5.191

8.  Crystallographic and receptor binding characterization of Plasmodium falciparum macrophage migration inhibitory factor complexed to two potent inhibitors.

Authors:  Georgios Pantouris; Deepa Rajasekaran; Alvaro Baeza Garcia; Victor G Ruiz; Lin Leng; William L Jorgensen; Richard Bucala; Elias J Lolis
Journal:  J Med Chem       Date:  2014-10-08       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.